Should You Go Up a Dose on Mounjaro? What the Evidence Says

The biggest misconception: higher dose always means better results

Most people starting Mounjaro assume they should reach 15 mg as quickly as possible. That's understandable, the strongest headline figures from clinical trials come from the highest dose. But it isn't how the medicine works in practice, and it isn't how a good prescriber approaches titration.

The licensed schedule starts at 2.5 mg for the first four weeks. That starting strength isn't there to produce weight loss; it exists to settle your digestive system before a therapeutic dose begins. Moving too fast through the lower rungs almost always produces worse nausea and vomiting, which itself disrupts eating patterns and increases the chance of stopping treatment altogether.

SURMOUNT-1, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% at 15 mg over 72 weeks, but participants followed a structured titration, not an accelerated one. The trial's design reflects what works. Chasing a higher number on the pen sooner than your body is ready for it tends to produce side effects, not faster weight loss.

The question isn't whether you can go up. It's whether going up right now is the right move for you.

What your prescriber actually looks at before increasing your dose

A question our prescribers hear most weeks is some version of: "I've been on this dose for a month, can I go up now?" The honest answer is: maybe. It depends on several things happening at once.

Weight-loss response matters, but it's only part of the picture. A prescriber will want to know how you're tolerating the current dose. If nausea is still noticeable, rushing to the next strength almost guarantees it gets worse. If you've settled in and side effects have largely passed, a move upward is more likely to be appropriate. The NHS tirzepatide guidance reflects this: titration is guided by tolerability, not by time alone.

Your weight trajectory also feeds in. If you're losing steadily at your current dose and tolerating it well, there's a reasonable clinical case for staying put rather than increasing. Some people reach a plateau that genuinely warrants a higher strength; others are still responding and don't need to move. The detail on what that looks like for 5 mg specifically is covered in our guide to moving from 2.5 mg to 5 mg.

For anyone transferring from another provider or requesting an increase at repeat, evidence of your current dose and recent progress is part of the clinical review. That's good practice, not a barrier.

When staying at your current dose is the right call

There's a version of this conversation that rarely comes up in forums: sometimes the right answer is to stay where you are. Dose increases carry real trade-offs. Each step up the titration ladder brings a fresh adjustment period (typically a week or two where GI side effects can flare) and for many people at 5 mg or 7.5 mg, weight loss is continuing at a pace that doesn't clinically justify the disruption of going higher.

If you're weighing up whether 7.5 mg is the right next step, the considerations are slightly different again; the 7.5 mg titration guide goes into that in detail. Similarly, the decision around moving to 10 mg involves its own clinical reasoning.

The broader principle holds at every step: the goal is the lowest effective dose for you, not the highest available. Some people reach their target weight at 7.5 mg and stay there. Some need 15 mg to get traction. Neither is more or less successful, they're just different clinical pictures.

For a fuller look at what the dose-increase decision involves across the whole schedule, the guide on when to go up a dose covers the timing and criteria in more depth. And if cost is a factor in how you're thinking about treatment, the Mounjaro price comparison page sets out what the UK market looks like honestly.

At nume, every repeat order is reviewed by a GPhC-registered prescriber before it's approved, including any dose change. That review isn't a formality. It's the point at which clinical judgement applies to your specific situation, not a general recommendation. If you'd like to talk through where you are in the titration process, start a free consultation and a prescriber will look at your case properly.